Citation: | GUO Jiajia, PENG Yuan, WANG Shu. Prognosis-related Factors of Bilateral Primary Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(02): 150-153. DOI: 10.3971/j.issn.1000-8578.2015.02.011 |
[1] |
Awad AT, el-Husseini G, Anwar M, et al. Bilateral primary breast cancers: a clinicopathological study of the second primary[J]. Int Surg, 1996, 81(1): 57-60.
|
[2] |
Chaudary MA, Millis RR, Hoskins EO, et al. Bilateral primary breast cancer: a prospective study of disease incidence[J]. Br J Surg, 1984, 71(9): 711-4.
|
[3] |
Fisher ER, Palekar AS, Gregorio RM, et al. Pathological findings from the national surgical adjuvant breast project(Protocol No. 4) Ⅳ. Significance of tumor necrosis[J]. Hum Pathol, 1978, 9(5): 52 3-30.
|
[4] |
Zhang S, Zhang XL, Hao XM, et al. Analysis of clinical and pathological features of 565 cases of bilateral primary breast cancer[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(6): 632-6.[张晟, 张霄蓓, 郝晓甍, 等. 565例双侧原发性乳腺癌临床病理特征分 析[J] 肿瘤防治研究, 2012, 39(6): 632-6. ]
|
[5] |
Setz-Pels W, Duijm LE, Groenewoud JH, et al. Patient and tumor characteristics of bilateral breast cancer at screening mammography in the Netherlands, a population-based study[J]. Breast Cancer Res Treat, 2011, 129(3): 955-61.
|
[6] |
Wang T, Liu H, Chen KX, et al. The risk factors and prognosis of bilateral primary breast cancer: a comparative study with unilateral breast cancer[J]. Oncol Res, 2011, 19(3-4): 171-8.
|
[7] |
Beckmann KR, Buckingham J, Craft P, et al. Clinical characteristics and outcomes of bilateral breast cancer in an Australian cohort[J]. Breast, 2011, 20(2): 158-64.
|
[8] |
Newman LA, Sahin AA, Cunningham JE, et al. A case-control study of unilateral and bilateral breast carcinoma patients[J]. Cancer, 2001, 91(10): 1845-53.
|
[9] |
Vuoto HD, García AM, Candás GB, et al. Bilateral breast carcinoma: clinical characteristics and its impact on survival[J]. Breast J, 2010, 16(6): 625-32.
|
[10] |
Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics[J]. Breast Cancer Res Treat, 2011, 126(1): 131-40.
|
[11] |
Kollias J, Pinder SE, Denley HE, et al. Phenotypic similarities in bilateral breast cancer[J]. Breast Cancer Res Treat, 2004, 85(3): 25 5-61.
|
[12] |
Huo D, Melkonian S, Rathouz PJ, et al. Concordance in histological and biological parameters between first and second primary breast cancers[J]. Cancer, 2011, 117(5): 907-15.
|
[13] |
Heron DE, Komarnicky LT, Hyslop T, et al. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease[J]. Cancer, 2000, 88(12): 27 39-50.
|
[14] |
Díaz R, Munárriz B, Santaballa A, et al. Synchronous and metachronous bilateral breast cancer: a long-term singleinstitution experience[J]. Med Oncol, 2012, 29(1): 16-24.
|
[15] |
Liang X, Li D, Geng W, et al. The prognosis of synchronous and metachronous bilateral breast cancer in Chinese patients[J]. Tumour Biol, 2013, 34(2): 995-1004.
|
[16] |
Kollias J, Pinder SE, Denley HE, et al. Phenotypic similarities in bilateral breast cancer[J]. Breast Cancer Res Treat, 2004, 85(3): 25 5-61.
|
[1] | LI Hongfei, TANG Weizhong, HUANG Qinglu, HUANG Kezeng, CAI Shangkun. Effect of Oxaliplatin on CD44V6, VEGF, survivin, Caspase-3 and Caspase-7 in Dimethylhydrazine-induced Colon Cancer Rats[J]. Cancer Research on Prevention and Treatment, 2015, 42(06): 560-563. DOI: 10.3971/j.issn.1000-8578.2015.06.006 |
[2] | Nie Yanli, Ruan Zhiping, Nan Kejun. Expressions of DR5,caspase-8,caspase-9 and caspase-3 in HepG2 Cell Line Treated with Gemcitabine[J]. Cancer Research on Prevention and Treatment, 2013, 40(02): 134-137. DOI: 10.3971/j.issn.1000-8578.2013.02.003 |
[3] | DING Hui, LI Xian-ming, GAO Yan, HU Li-xia, YANG Dong, ZHOU Ya-yan, XU Gang. Expression and Significance of HIF-2α and Caspase-3 in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2011, 38(01): 41-44. DOI: 10.3971/j.issn.1000-8578.2011.01.012 |
[4] | WANG Feng-qi, ZHAO Wei-ming, ZHANG Cheng, JIN Cheng-jun, ZHANG Zi-jian, ZHONG Zhao-hua, XIU You-cheng. Experimental of Combining Therapy with IL-12 Gene and THP in Bladder Cancer Nude Mice Model[J]. Cancer Research on Prevention and Treatment, 2010, 37(11): 1241-1244. DOI: 10.3971/j.issn.1000-8578.2010.11.008 |
[5] | WANG Ya-li, WANG Zhong-wei, WANG Xi-jing, JIN Ying-ying. Caspase-3 Gene of Mediating X radiation Induced Apoptosis in Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 541-544. DOI: 10.3971/j.issn.1000-8578.2009.07.001 |
[6] | ZHANG Xiao-Juan, WANG Na, ZHOU Rong-Miao, DONG Xiu-Juan, LI Yan. Correlation of MMP-12 Polymorphism to Risk of Squamous Cell Carcinoma and Gastric Cardiac Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2008, 35(10): 740-743. DOI: 10.3971/j.issn.1000-8578.2861 |
[7] | WANG Yan-yan, SONG Xing-fu, CUI Xiang-jun, HUANG Ji. Apoptosis Induced by Artesunate in Human Adenocarcinoma Cell Line A549 Cells Associated with Activation of caspase-9 and caspase-3[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 651-653. DOI: 10.3971/j.issn.1000-8578.2020 |
[8] | HUANG Wen-fang, YANG Yong-chang, LIU Hua, CHEN Jiang, ZHOU Ding-an. Changes of Caspase-3 and Caspase-9 Activity during the Simvastatin-induced Apoptosis in K562 Cells[J]. Cancer Research on Prevention and Treatment, 2007, 34(01): 39-41. DOI: 10.3971/j.issn.1000-8578.1221 |
[9] | YE Shu-nan, YANG Shu-hua, YANG Chao, XU Wei-hua. A Tumor-targeted Vector for Interleukin-12 Gene Therapy to Enhance the Anti-osteosarcoma Immunity in Nude Mouse[J]. Cancer Research on Prevention and Treatment, 2005, 32(05): 305-307. DOI: 10.3971/j.issn.1000-8578.2424 |
[10] | YE Shu-nan, YANG Shu-hua, WU Qiang, YANG Cao, LI Jing, XU Wei-hua. Polythylenimine AS A Nonviral Vector for Murine Interleukin-12 Gene Transfer to the Mouse Osteosarcoma Cells[J]. Cancer Research on Prevention and Treatment, 2005, 32(02): 96-98. DOI: 10.3971/j.issn.1000-8578.693 |